Unfortunately, as a compound, glutathione is hard to supplement successfully
Following its placement in Category 2 of the FDA's 503A interim bulk-substances policy, BPC-157 is not eligible for pharmacy compounding for human use
However, the risk for thyroid cancer was significantly higher within the first year after GLP-1RA initiation and was amplified in the overall as-treated analysis that censored patients when therapy was discontinued or another medication was added. The research team indicates this could be a sign that GLP-1 users are being screened for thyroid cancer at a higher rate than other diabetes drugs, resulting in a spike in diagnoses in the first year of taking the drug
Rohayem J, Haffner D, Cremers JF, Huss S, Wistuba J, Weitzel D, Kliesch S, Hohenfellner K (2021) Testicular function in males with infantile nephropathic cystinosis
Slower stomach emptying affects how our bodies handle blood sugar after eating